Reoporte 2025 8k2 - IGC Pharma, INC.

Skip to content

Home
Stock Info
Press Releases
SEC Filings
Company
- Our Team
- Governance
- ESG

Home
Stock Info
Press Releases
SEC Filings
Company
- Our Team
- Governance
- ESG

Search

SEC Filings Details

Investor Relations > SEC Fillings > SEC Fillings Details

Quarterly Filings

January 28, 2025

Reoporte 2025 8k2

Subscribe to Newsletter

Subscribe to get our latest content by email.

Potomac, MD, USA
info@igcpharma.com
+1 301-983-0998

COMPANY

CEO Update
Deck
Board/Executives
Governance
ESG
Privacy Policy

FINANCIALS

SEC Filings
Proxy Materials
Press Releases

TRADING & DATA

NYSE: IGC
Börse Berlín IGS1.BE
Börse frankfurt IGS1.F
Börse Munich IGS1.MU
Börse Stuttgart IGS1.SG
Tradegate Exchange

IGC Pharma, INC. © 2026

X-twitter Facebook-f Linkedin